Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thymoglobulin Dose”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00288626
What this trial is testing

High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID) 25
Post-approval studies (Phase 4)UnknownNCT03088280
What this trial is testing

Efficacy and Safety of Rabbit Antithymocyte Globulin 3mg/kg in Kidney Transplant Patients Under Steroid-free and CNI Minimization Maintenance Immunosuppressive Regimen

Who this might be right for
Thymoglobulin Dose
Hospital Geral de Fortaleza 200
Testing effectiveness (Phase 2)Study completedNCT00089947
What this trial is testing

Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant Rejection

Who this might be right for
Renal TransplantationGraft Rejection
Genzyme, a Sanofi Company 150
Testing effectiveness (Phase 2)UnknownNCT03395860
What this trial is testing

Low Dose ATG Plus Low Dose PTCy as GVHD Prophylaxis in Haplo-HSCT

Who this might be right for
Graft-versus-host-diseaseProphylaxis
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 100
Not applicableEnded earlyNCT00235781
What this trial is testing

Single Dose Thymoglobulin for Induction in Adult Renal Allograft Recipients

Who this might be right for
Kidney Transplantation
Washington University School of Medicine 90
Large-scale testing (Phase 3)UnknownNCT01844635
What this trial is testing

Randomised Study Comparing Different Dosages of Rabbit ATG in Patients With SAA

Who this might be right for
Acquired Aplastic Anemia.
Nagoya University 320
Testing effectiveness (Phase 2)Active Not RecruitingNCT04872595
What this trial is testing

A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant

Who this might be right for
Acute Myeloid Leukemia (AML)Acute Lymphoid Leukemia (ALL)Myelodysplastic Syndromes (MDS)
Memorial Sloan Kettering Cancer Center 59
Not applicableUnknownNCT06039436
What this trial is testing

Conditioning Regimen Containing Low Dose ATG for The Treatment of Acquired SAA Receiving sUCBT

Who this might be right for
Severe Aplastic Anemia
Anhui Provincial Hospital 72
Large-scale testing (Phase 3)UnknownNCT00934557
What this trial is testing

Randomized Study of ATG for Graft Versus Host Disease (GVHD) Prevention in Paediatric Patients Given an Unrelated Donor Stem Cell Transplantation

Who this might be right for
Paediatric Patients Affected by Haematological Malignancies and Eligible to Undergo HSCT From an Unrelated Volunteer
Fondazione IRCCS Policlinico San Matteo di Pavia 42
Testing effectiveness (Phase 2)Looking for participantsNCT07508787
What this trial is testing

A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant

Who this might be right for
Renal Transplant Failure and Rejection
Nefro Avillion Clinical Development, LLC 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT00716066
What this trial is testing

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Who this might be right for
Autoimmune DiseaseNeurologic Autoimmune DiseaseAutologous Transplant Autoimmune+16 more
Fred Hutchinson Cancer Center 53
Testing effectiveness (Phase 2)Study completedNCT00906204
What this trial is testing

Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation

Who this might be right for
End-Stage Renal DiseaseKidney Failure
Wright State University 99
Testing effectiveness (Phase 2)Study completedNCT01490723
What this trial is testing

Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 20